Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of June 2025. The report specifically details a transaction in the company's own shares executed under its share buyback programme announced on March 28, 2025.
Key Financial Metrics and Transaction Details
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on share repurchase activity:
- Date of Purchase: June 10, 2025
- Shares Purchased: 972,579 ordinary shares
- Price Range: Lowest 395.20p; Highest 399.20p
- Volume Weighted Average Price: 396.85p
- Post-Transaction Capital: 8,999,475,387 ordinary shares registered; 4,080,205 held as treasury shares.
- Voting Shares: 8,995,395,182 ordinary shares with voting rights.
Material Changes
The primary material change is the reduction in the number of outstanding shares due to the cancellation of 972,579 shares purchased on June 10, 2025. This transaction reduces the total registered share capital and the number of shares with voting rights.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, management commentary on operational performance, or discussion of risks and contingencies. It is a regulatory disclosure of a specific share transaction. The document includes a standard disclaimer stating it does not constitute an offer or solicitation for securities.
Key Facts for Investor Verification
- Verify the total number of shares repurchased to date under the March 28, 2025 Buyback Programme.
- Confirm the current market price relative to the 396.85p average purchase price.
- Review the full trade breakdown available via the provided London Stock Exchange link for granular execution details.
- Check subsequent filings for updates on the remaining authorization for the share buyback programme.